HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy.

AbstractPURPOSE:
In this study, we aimed to evaluate the efficacy of peribulbar triamcinolone injections to treat inflammatory signs of Graves' ophthalmopathy (GO) in patients with moderate to severe GO and associated optic neuropathy (ON).
METHODS:
Twenty-one patients with active GO [clinical activity score (CAS) > or = 4] and systemic thyroid disease under control were enrolled in this prospective pilot study. Peribulbar triamcinolone acetonide was injected in each orbit (42 eyes), in four doses of 20 mg at 2-week intervals. Ophthalmological examination including CAS evaluation, visual field, computerized tomography (CT) scan and digital photography were performed before and after treatment.
RESULTS:
Twenty-one patients (11 with moderate disease, 10 with ON) were enrolled in this study and followed for at least 14 months. Initial mean CAS was 6.38 +/- 1.49, which dropped to 1.8 +/- 1.12 after 6 months of treatment (P = 0.01; mean difference of 4.57 +/- 1.56; range 1-8 score points). ON was diagnosed in 10 patients. Of these, 66% improved with peribulbar triamcinolone exclusively. A transitory increase in intraocular pressure in two patients was controlled with topic medication.
CONCLUSION:
Peribulbar triamcinolone injections reduce the inflammatory signs of moderate GO, as measured by the CAS, and could also be used as an alternative treatment for ON. Randomized clinical trials are needed to compare the results of triamcinolone peribulbar injections to those of other treatment modalities.
AuthorsMarcela Bordaberry, Daniela L Marques, Julio C Pereira-Lima, Italo M Marcon, Helena Schmid
JournalActa ophthalmologica (Acta Ophthalmol) Vol. 87 Issue 1 Pg. 58-64 (Feb 2009) ISSN: 1755-3768 [Electronic] England
PMID18937809 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Glucocorticoids
  • Triamcinolone Acetonide
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Glucocorticoids (administration & dosage)
  • Graves Ophthalmopathy (diagnostic imaging, drug therapy)
  • Humans
  • Injections
  • Intraocular Pressure (drug effects)
  • Male
  • Middle Aged
  • Optic Nerve Diseases (diagnostic imaging, drug therapy)
  • Orbit
  • Pilot Projects
  • Prospective Studies
  • Retreatment
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Triamcinolone Acetonide (administration & dosage)
  • Visual Fields (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: